Slate Bio

Charlottesville, VA · Founded 2020 · Privately Held (backing)

Developer of a therapeutic platform intended to offer immunotherapeutics to resist autoimmune and inflammatory diseases. Slate Bio is based in Charlottesville, VA and was founded in 2020. It was valued at $11.3 million at its seed round in May 2023, the last priced event on record. It has raised $6 million across 2 recorded rounds; the latest was a $2.8 million seed round in Dec 2022.

PMV mark · valuation
$11.3M
Oct 2026
Priced at
its seed round
May 2023
Total raised
$6.0M
Last round
Seed Round
Dec 2022

Who backs Slate Bio?

8 investors
InvestorType
Virginia Innovation Partnership CorporationVenture capital
Virginia Venture PartnersVenture capital
CAV AngelsAngel
University of VirginiaOther
Epidarex Capital—
PharmaDirections—
UVA LVG Seed Fund—
VTC Ventures—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Slate Bio investors

8 investors are on record for Slate Bio, including Virginia Innovation Partnership Corporation, Virginia Venture Partners, CAV Angels and University of Virginia. The seed round in Dec 2022 drew 9 investors.

Free account
More of Slate Bio with a free account
  • ·Watch Slate Bio: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 8 firms already write checks for companies like Slate Bio. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View